15 results
DEF 14A
CTKB
Cytek BioSciences Inc
14 Apr 22
Definitive proxy
4:01pm
) and (ii) of the Nasdaq listing standards).
The Board has also determined that Ms. Dion qualifies as an “audit committee financial expert,” as defined
424B4
CTKB
Cytek BioSciences Inc
23 Jul 21
Prospectus supplement with pricing info
4:12pm
is Gisele Dion. Our board of directors has determined that Gisele Dion is an “audit committee financial expert” within the meaning of SEC regulations … is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Canada
The shares of our common stock may
S-1/A
lz0jba05kfnot
13 Jul 21
IPO registration (amended)
9:03pm
S-1
r1s cygjgn
2 Jul 21
IPO registration
4:34pm
S-1
EX-10.12
0y3me6
2 Jul 21
IPO registration
4:34pm
S-1
EX-10.14
av66xkmssuxmi1p js
2 Jul 21
IPO registration
4:34pm
DRS/A
EX-10.12
x1tbk1h
14 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
r22k77ps cnlfycx
14 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
ofvz5u
14 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.12
c1ukfr95br3w
22 Apr 21
Draft registration statement
12:00am
DRS
lsaumdmf
22 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next